Panthera Biopharma, LLC

UEI
UFSEPG4LASN7
CAGE
Not on record
Primary NAICS
Not on record
SAM.gov registration
Expired

Company facts

Entity structure
Other

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
Base period HDTRA113C0007 Defense Contract Management Agency $11,090,280
CSI tatrc r & d proposal #10027002 W81XWH10C0287 Medical Command (Army) $4,559,598
Tatrc r & d proposal #08106002 W81XWH09C0091 Medical Command (Army) $1,623,223

Grant awards

Award Agency Obligated Awarded
Discovery of broad spectrum dengue virus proteinase inhibitors R43AI079966 National Institutes of Health $599,957
Antidotes to anthrax lethal factor intoxication U01AI078067 National Institutes of Health $5,302,002
Development of a recombinant subunit ebola vaccine R43AI066616 National Institutes of Health $479,882
Optimization of small molecule botulinum neurotoxin inhibitors R43AI069637 National Institutes of Health $509,587
Discovery of west nile virus protease inhibitors R43AI069584 National Institutes of Health $499,989

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is Panthera Biopharma, LLC registered in SAM.gov?

Panthera Biopharma, LLC's SAM.gov registration expired on February 22, 2013.

What is Panthera Biopharma, LLC's most recent federal award?

Panthera Biopharma, LLC's most recent federal contract award is Base period (HDTRA113C0007), from Defense Contract Management Agency, on February 22, 2013.

On GovTribe

See Panthera Biopharma, LLC's full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login